ArticleFrontiers in medicine2022

Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series.

Zaiwei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.